elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45898690-71E6F6FD-F215-4805-8A41-A08C68252219
Q45898690-71E6F6FD-F215-4805-8A41-A08C68252219
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45898690-71E6F6FD-F215-4805-8A41-A08C68252219
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.
P356
Q45898690-71E6F6FD-F215-4805-8A41-A08C68252219
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45898690-71E6F6FD-F215-4805-8A41-A08C68252219
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
425fab063fac636a8b3648c6805e8c82ae003549
P356
10.2217/CRC.12.13
http://www.w3.org/2001/XMLSchema#string
P356
CRC.12.13